FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma

BACKGROUND: Previous studies have elucidated that FOXM1 may predict poor prognosis in patients with multiple solid malignant tumors. In this study we explored the differential expression of FOXM1 in stage IIA esophageal squamous cell carcinoma (ESCC) and investigated its prognostic value. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zhaohua, Jia, Yang, Jiang, Wenpeng, Wang, Zhou, Zhang, Zhiping, Gao, Yanyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068428/
https://www.ncbi.nlm.nih.gov/pubmed/29877046
http://dx.doi.org/10.1111/1759-7714.12776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068428/
https://www.ncbi.nlm.nih.gov/pubmed/29877046
http://dx.doi.org/10.1111/1759-7714.12776

Ejemplares similares